Target intelligence / Profile preview

NELL1 antisense RNA 1 (NELL1-AS1)

Target
NELL1-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA
01

Overview

NELL1 antisense RNA 1 (NELL1-AS1) is a long noncoding RNA transcribed from the antisense strand of the NELL1 gene locus. As an antisense RNA, NELL1-AS1 may regulate NELL1 gene expression through transcriptional interference, chromatin modification, and RNA–RNA interactions. Like other antisense lncRNAs, it may act in cis (locally) or trans (at a distance) to modulate the transcription, stability, or translation of the sense NELL1 transcript. While the NELL1 protein is implicated in diseases such as osteosarcoma and is a candidate for therapeutic intervention, the specific biological roles and disease associations of NELL1-AS1 are not currently well characterized in the literature and require further research.

Other names
NELL1-AS1NELL1 antisense RNA 1
02

Mechanism of action

Not applicable, as no drugs target NELL1-AS1 directly. Theoretical mechanisms for drugs targeting antisense RNAs include inhibition via ASOs and modulation of gene expression through RNA interference or epigenetic effects.

03

Biological functions

Gene expression regulation (as antisense RNA, can modulate transcription of the NELL1 gene through various mechanisms such as transcriptional interference, chromatin modification, or RNA–RNA interactions)Potential involvement in epigenetic regulation
04

Disease associations

Potential role in regulation of NELL1 gene, which has implications for cancer biology, especially bone tumors/osteosarcoma (lncRNA itself has not been specifically described in disease contexts, but similar antisense RNAs are often studied for their roles in cancer and development)
05

Safety considerations

No known safety concerns or therapeutic challenges associated directly with NELL1-AS1 as it is not a drug target.General challenges for antisense RNAs as therapeutic targets include off-target effects, potential toxicity from nucleic acid therapeutics, and specificity of gene regulation.

Beyond the preview

Go deeper on NELL1 antisense RNA 1 (NELL1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NELL1 antisense RNA 1 (NELL1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call